Viewing StudyNCT02446717



Ignite Creation Date: 2024-05-06 @ 4:03 AM
Last Modification Date: 2024-10-26 @ 11:43 AM
Study NCT ID: NCT02446717
Status: COMPLETED
Last Update Posted: 2017-09-15
First Post: 2015-05-14

Brief Title: A Study to Evaluate the Efficacy Safety and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy
Sponsor: AbbVie
Organization: AbbVie

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-04
Start Date Type: ACTUAL
Primary Completion Date: 2016-12
Primary Completion Date Type: ACTUAL
Completion Date: 2017-01
Completion Date Type: ACTUAL
First Submit Date: 2015-05-14
First Submit QC Date: May 14 2015
Study First Post Date: 2015-05-18
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2017-09-15
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2017-01-31
Disp First Submit QC Date: January 31 2017
Disp First Post Date: 2017-02-01
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2017-08-17
Last Update Post Date: 2017-09-15
Last Update Post Date Type: ACTUAL